ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

130
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
bullishAstellas Pharma
31 Oct 2024 17:05

Astellas Pharma (4503 JP): US Momentum Drives 1HFY25 Result; Guidance Revised Upward

​Astellas Pharma reported 22% revenue growth in H1FY25 driven by Xtandi sales The company raises guidance for FY25 with Xtandi and Padcev being key...

Logo
177 Views
Share
bearishAstellas Pharma
26 Apr 2024 23:29

Astellas Pharma (4503 JP): Fx Drives FY24 Revenue; Impairment Loss Dents Profits; Pain to Continue

For FY25, Astellas Pharma guided for just 3% revenue growth. FY25 core operating profit is expected to decline 10%, while net profit is anticipated...

Logo
520 Views
Share
03 Nov 2024 07:30

APAC Healthcare Weekly (Nov 3)- Eisai, Takeda, Shionogi, Astellas Pharma, Celltrion, Wuxi AppTec

Large APAC healthcare companies are reporting mixed earnings. Demography will play a key role in ensuring how the overall domestic demand scenario...

Logo
461 Views
Share
bullishAstellas Pharma
15 Dec 2023 09:30

Astellas Pharma (4503 JP): Some Recent Positive Developments That Will Yield Benefit in Long-Run

​Astellas Pharma has been reporting a couple of positive developments over the last one month, including European approval of potential blockbuster...

Logo
540 Views
Share
bullishSumitomo Pharma
19 May 2022 19:25

Sumitomo Dainippon Pharma Co (4506 JP): New Launches Ensure Post-Latuda Growth Trajectory

Sumitomo is on right track to alleviate patent cliff through new launches in the U.S. The company’s three new U.S. products have potential for...

Logo
389 Views
Share
x